1. Home
  2. ABOS vs REE Comparison

ABOS vs REE Comparison

Compare ABOS & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABOS
  • REE
  • Stock Information
  • Founded
  • ABOS 1996
  • REE 2011
  • Country
  • ABOS United States
  • REE Israel
  • Employees
  • ABOS N/A
  • REE N/A
  • Industry
  • ABOS Biotechnology: Pharmaceutical Preparations
  • REE Auto Manufacturing
  • Sector
  • ABOS Health Care
  • REE Consumer Discretionary
  • Exchange
  • ABOS Nasdaq
  • REE Nasdaq
  • Market Cap
  • ABOS 66.6M
  • REE 77.3M
  • IPO Year
  • ABOS 2021
  • REE N/A
  • Fundamental
  • Price
  • ABOS $0.98
  • REE $3.29
  • Analyst Decision
  • ABOS Strong Buy
  • REE Strong Buy
  • Analyst Count
  • ABOS 3
  • REE 3
  • Target Price
  • ABOS $7.33
  • REE $12.50
  • AVG Volume (30 Days)
  • ABOS 215.0K
  • REE 98.2K
  • Earning Date
  • ABOS 05-13-2025
  • REE 05-29-2025
  • Dividend Yield
  • ABOS N/A
  • REE N/A
  • EPS Growth
  • ABOS N/A
  • REE N/A
  • EPS
  • ABOS N/A
  • REE N/A
  • Revenue
  • ABOS N/A
  • REE $626,000.00
  • Revenue This Year
  • ABOS N/A
  • REE N/A
  • Revenue Next Year
  • ABOS N/A
  • REE $18,744.14
  • P/E Ratio
  • ABOS N/A
  • REE N/A
  • Revenue Growth
  • ABOS N/A
  • REE N/A
  • 52 Week Low
  • ABOS $0.86
  • REE $2.31
  • 52 Week High
  • ABOS $3.92
  • REE $11.72
  • Technical
  • Relative Strength Index (RSI)
  • ABOS 43.50
  • REE 53.78
  • Support Level
  • ABOS $0.96
  • REE $2.68
  • Resistance Level
  • ABOS $1.13
  • REE $3.25
  • Average True Range (ATR)
  • ABOS 0.08
  • REE 0.26
  • MACD
  • ABOS 0.00
  • REE 0.14
  • Stochastic Oscillator
  • ABOS 10.71
  • REE 68.34

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

About REE REE Automotive Ltd.

REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.

Share on Social Networks: